Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
13,117,480
-
Shares change
-
-298,186
-
Total reported value, excl. options
-
$348,994,653
-
Value change
-
+$837,826
-
Put/Call ratio
-
40%
-
Number of buys
-
76
-
Number of sells
-
54
-
Price
-
$26.61
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q3 2016
As of 30 Sep 2016 ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) had 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,117,480 shares of stock of the company.
Largest 10 holders included BlackRock Fund Advisors, Krensavage Asset Management, LLC, GREAT POINT PARTNERS LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, SENZAR ASSET MANAGEMENT, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, FMR LLC, AJO, LP, and BlackRock Institutional Trust Company, N.A..
This table shows 156 institutional shareholders of the security as of 30 Sep 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.